In its 24 November 2017 edition, the economic magazine of Bilan devoted a section to philanthropy for research in Switzerland.
EspeRare is featured in an article about the muliple ways to do Philanthropy in the research area. The interview with Caroline Kant, CEO of EspeRare, emphasises the urgency of finding accessible treatments to impact the lives of children with rare diseases. She then explains how the foundation's philanthropic venture model allow to accelerate to fight for rare diseases.